Author

Niki S.M. Schoonenboom

Observed names: N. S.M. Schoonenboom, N. Schoonenboom, N.S.M. Schoonenboom, Niki S. M. Schoonenboom, Niki S. Schoonenboom, Niki S.N.M. Schoonenboom, Niki SM Schoonenboom, Niki Schoonenboom, Niki Sm Schoonenboom, Schoonenboom, N.S.M., Schoonenboom, Niki

Institution: Spaarne Gasthuis

Observed institutions: University of Milan, Trinity College Dublin, Erasmus MC, Slotervaartziekenhuis, Amsterdam UMC Location University of Amsterdam, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Noordwest Ziekenhuisgroep, Haga Hospital, Spaarne Gasthuis, Ludwig-Maximilians-Universität München, Vrije Universiteit Amsterdam, University of Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam

ORCID: 0000-0001-7158-6449

Observed ORCID: 0000-0001-7158-6449

OpenAlex ID: A5069663048

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

2011 · N.S.M. Schoonenboom, F.E. Reesink, et al. · Neurology · 304

Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease

2006 · Daniela Galimberti, Niki Schoonenboom, et al. · Archives of Neurology · 289

Amyloid β(1–42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease

2004 · N. S.M. Schoonenboom, Y. A.L. Pijnenburg, et al. · Neurology · 181

Effects of Processing and Storage Conditions on Amyloid β (1–42) and Tau Concentrations in Cerebrospinal Fluid: Implications for Use in Clinical Practice

2004 · Niki SM Schoonenboom, Cees Mulder, et al. · Clinical Chemistry · 165

PDF

Inflammatory markers in AD and MCI patients with different biomarker profiles

2008 · Alie Schuitemaker, Miranda G. Dik, et al. · Neurobiology of Aging · 150

Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI

2007 · M. Ewers, K. Buerger, et al. · Neurology · 146

CSF biomarker levels in early and late onset Alzheimer's disease

2008 · Femke H. Bouwman, Niki S.M. Schoonenboom, et al. · Neurobiology of Aging · 142

Longitudinal changes of CSF biomarkers in memory clinic patients

2007 · F. H. Bouwman, W. M. van der Flier, et al. · Neurology · 121

Amyloid β 38, 40, and 42 species in cerebrospinal fluid: More of the same?

2005 · Niki S. Schoonenboom, Cees Mulder, et al. · Annals of Neurology · 120

Chemokines in serum and cerebrospinal fluid of Alzheimer's disease patients

2003 · Daniela Galimberti, Niki Schoonenboom, et al. · Annals of Neurology · 116

CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease

2007 · Niki S.M. Schoonenboom, Wiesje M. van der Flier, et al. · Neurobiology of Aging · 109

Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project

2018 · Eline A.J. Willemse, Ingrid S. van Maurik, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 106

PDF

CSF Neurofilaments in Frontotemporal Dementia Compared with Early Onset Alzheimer’s Disease and Controls

2007 · Yolande A.L. Pijnenburg, John C. Janssen, et al. · Dementia and Geriatric Cognitive Disorders · 82

Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration

2006 · D. Galimberti, N. Schoonenboom, et al. · Neurology · 82

Total tau and Phosphorylated tau 181 Levels in the Cerebrospinal Fluid of Patients With Frontotemporal Dementia Due to P301L and G272V tau Mutations

2003 · Sonia M. Rosso, Esther van Herpen, et al. · Archives of Neurology · 77

Functional Brain Connectivity and Neurocognitive Functioning in Patients With Long-Standing Type 1 Diabetes With and Without Microvascular Complications

2009 · Eelco van Duinkerken, Martin Klein, et al. · Diabetes · 74

Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design

2017 · Arno de Wilde, Ingrid S. van Maurik, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 70

PDF

Development and Usability of ADappt: Web-Based Tool to Support Clinicians, Patients, and Caregivers in the Diagnosis of Mild Cognitive Impairment and Alzheimer Disease

2019 · Ingrid S van Maurik, Leonie NC Visser, et al. · JMIR Formative Research · 69

Patients' and caregivers' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project

2017 · Marleen Kunneman, Ruth Pel‐Littel, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 68

PDF

The transmethylation cycle in the brain of Alzheimer patients

2005 · Cees Mulder, Niki S.M. Schoonenboom, et al. · Neuroscience Letters · 51

Clinicians' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project

2017 · Marleen Kunneman, Ellen M.A. Smets, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 42

PDF

CSF tau and Aβ42 are not useful in the diagnosis of frontotemporal lobar degeneration

2004 · Y. A.L. Pijnenburg, N. S.M. Schoonenboom, et al. · Neurology · 35

Decision tree supports the interpretation of CSF biomarkers in Alzheimer's disease

2018 · Rosha Babapour Mofrad, Niki S.M. Schoonenboom, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 34

PDF

Acute response to cholinergic challenge predicts long‐term response to galantamine treatment in patients with Alzheimer's disease

2021 · Anne Catrien Baakman, Carmen Gavan, et al. · British Journal of Clinical Pharmacology · 19

PDF

A novel cognitive‐functional composite measure to detect changes in early Alzheimer's disease: Test–retest reliability and feasibility

2017 · Roos J. Jutten, John Harrison, et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 19

PDF

Works count: 73

Citation count: 2,796

H-index: 23

I10-index: 31